Search Results 171-180 of 17471 for Vitiligo

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Melasma, Alopecia areata. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann, M.D.. Otolaryngologist.

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder ...

  3. A Study of the Long-Term Occurrence of Skin Cancer in Patients who were Treated with Phototherapy as a Child - Mayo Clinic

    Indication of phototherapy was for atopic dermatitis, psoriasis, vitiligo, and pruritus; Type of phototherapy was PUVA/UVA, broadband UVB, or narrowband UVB ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder ...

  5. A Study to Evaluate Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC - Mayo Clinic

    Subjects with vitiligo or alopecia;; Subjects with hypothyroidism (e.g., following Hashimoto syndrome) stable on hormone replacement;; Any chronic skin ...

  6. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    Subject with vitiligo, alopecia, type I diabetes mellitus, and endocrine deficiencies including hypothyroidism managed with replacement hormones including ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder ...

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder ...

  9. Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) - Mayo Clinic

    ... vitiligo, and the laboratory values defined in the inclusion criteria: Patients with Grade ≥2 neuropathy will be evaluated on a case-by-case basis after ...

  10. A Study to Evaluate Immune-related Biomarkers for Pathological Response in Stage II-III HER2-positive Breast Cancer - Mayo Clinic

    Patients with vitiligo, Graves disease, or psoriasis not requiring systemic treatment within the past 30 days are not excluded. Patients with Celiac disease ...